granted patent: COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS

TitleCOMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS
Priority Date2006-04-25 US 11/745601P
Inventors
Issue Date2007
Citation
WO Patent WO 2007142757. World Intellectual Property Organization (WIPO), PatentScope, 2007 How to Cite?
AbstractCompositions which self-assemble under physiological conditions are formulate for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may als include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer.; The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatme such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination wit an oil and forms a laminate.; In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.
Persistent Identifierhttp://hdl.handle.net/10722/210490
References

 

DC FieldValueLanguage
dc.date.accessioned2015-06-17T07:02:36Z-
dc.date.available2015-06-17T07:02:36Z-
dc.date.issued2007-
dc.identifier.citationWO Patent WO 2007142757. World Intellectual Property Organization (WIPO), PatentScope, 2007-
dc.identifier.urihttp://hdl.handle.net/10722/210490-
dc.description.abstractCompositions which self-assemble under physiological conditions are formulate for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may als include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer.; The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatme such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination wit an oil and forms a laminate.; In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.-
dc.relation.isreferencedbyWO 2013123491 (A1) 2013-08-22-
dc.relation.isreferencedbyWO 2015035189 (A1) 2015-03-12-
dc.relation.isreferencedbyWO 2015027203 (A1) 2015-02-26-
dc.relation.isreferencedbyEP 2581097 (A1) 2013-04-17-
dc.relation.isreferencedbyWO 2008134544 (A1) 2008-11-06-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleCOMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS-
dc.typePatent-
dc.identifier.authoritySO, KWOK-FAI=rp00329-
dc.identifier.authorityLIANG, YU-XIANG=rp00510-
dc.identifier.authorityTAY, DAVID=rp00336-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorELLIS-BEHNKE, RUTLEDGE-
dc.contributor.inventorLIANG, YU-XIANG-
dc.contributor.inventorSCHNEIDER, GERALD E-
dc.contributor.inventorSO, KWOK-FAI-
dc.contributor.inventorTAY, DAVID-
patents.identifier.applicationPC T/US2007010041-
patents.description.assigneeMASSACHUSETTS INST TECHNOLOGY [US]; ELLIS-BEHNKE RUTLEDGE [US]; LIANG YU-XIANG [CN]; SCHNEIDER GERALD E [US]; SO KWOK-FAI [CN]; TAY DAVID [CN] -
patents.description.countryWorld Intellectual Property Organization (WIPO) -
patents.date.publication2007-12-13-
dc.relation.referencesUS 2006025524 (A1) 2006-02-02 -
dc.relation.referencesWO 9509659 (A1) 1995-04-13-
dc.relation.referencesXP 002398333-
dc.relation.references W O03084980 (A3) 2003-12-11-
dc.relation.referencesWO 03084980 (A2) 2003-10-16 -
dc.relation.references U S7884185 (B2) 2011-02-08-
patents.identifier.hkutechidAnat-2006-00186A-2-
patents.date.application2007-04-25-
patents.date.priority2006-04-25 US 11/745601P-
patents.description.ccwo-
patents.identifier.publicationWO 2007142757-
patents.relation.familyEP 2150268 (A1) 2010-02-10-
patents.relation.familyEP 2581097 (A1) 2013-04-17-
patents.relation.familyCA 2722465 (A1) 2008-11-06-
patents.relation.familyJP 2009535338 (A) 2009-10-01-
patents.relation.familyCA 2650230 (A1) 2007-12-13-
patents.relation.familyEP 2012842 (A2) 2009-01-14-
patents.relation.familyKR 20090015935 (A) 2009-02-12-
patents.relation.familyKR 20110091019 (A) 2011-08-10-
patents.relation.familyUS 2008032934 (A1) 2008-02-07-
patents.relation.familyUS 2008091233 (A1) 2008-04-17-
patents.relation.familyWO 2008134544 (A1) 2008-11-06-
patents.relation.familyAU 2007257425 (A1) 2007-12-13-
patents.relation.familyCN 101472620 (A) 2009-07-01-
patents.relation.familyJP 2010526779 (A) 2010-08-05-
patents.description.kindA2-
patents.typePatent_granted-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats